Login to Your Account



Clinic Roundup


Tuesday, December 18, 2012
• Fibrocell Science Inc., of Exton, Pa., said it plans to start a Phase II trial to test azficel-T in treating restrictive burn scars in the first quarter of 2013.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription